Mechanisms of Brain Iron Transport: Insight into Neurodegeneration and CNS Disorders

Astrocyte-endothelial interactions at the blood-brain barrier

Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595 · see citing works

Rab proteins as membrane organizers

Zerial, M., & McBride, H. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052055 · Cited by 3,381 · see citing works

Cloning and characterization of a mammalian proton-coupled metal-ion transporter

Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166 · see citing works

Iron, brain ageing and neurodegenerative disorders

Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801 · see citing works

Balancing Acts

Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736 · see citing works

Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667 · see citing works

The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis

Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275 · see citing works

An iron-regulated ferric reductase associated with the absorption of dietary iron

McKie, A. T., Barrow, D., Latunde-Dada, G. O., Rolfs, A., Sager, G., Mudaly, E., Mudaly, M., Richardson, C., Barlow, D., Bomford, A., et al. (2001) · Science · doi:10.1126/science.1057206 · Cited by 1,101 · see citing works

Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse

Vulpe, C. D., Kuo, Y.-M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., & Anderson, G. J. (1999) · Nature Genetics · doi:10.1038/5979 · Cited by 1,084 · see citing works

Transferrin receptor on endothelium of brain capillaries

Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061 · see citing works

The role of iron regulatory proteins in mammalian iron homeostasis and disease

Rouault, T. A. (2006) · Nature Chemical Biology · doi:10.1038/nchembio807 · Cited by 1,055 · see citing works

Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes

Reddy, A. J., Caler, E. V., & Andrews, N. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00421-4 · Cited by 1,043 · see citing works

Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells

Ohgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., Sharp, J. J., Fujiwara, Y., Barker, J. E., & Fleming, M. D. (2005) · Nature Genetics · doi:10.1038/ng1658 · Cited by 775 · see citing works

Intramuscular desferrioxamine in patients with Alzheimer's disease

MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764 · see citing works

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome

Zhou, B., Westaway, S. K., Levinson, B., Johnson, M., Gitschier, J. M., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 756 · see citing works

The Steap proteins are metalloreductases

Ohgami, R. S., Campagna, D. R., McDonald, A., & Fleming, M. D. (2006) · Blood · doi:10.1182/blood-2006-02-003681 · Cited by 744 · see citing works

Iron Deficiency and Brain Development

Lozoff, B., & Georgieff, M. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.004 · Cited by 711 · see citing works

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 706 · see citing works

Metals in Alzheimer's and Parkinson's Diseases

Barnham, K. J., & Bush, A. I. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.02.019 · Cited by 695 · see citing works

Iron Homeostasis

Andrews, N. C., & Schmidt, P. J. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.164337 · Cited by 640 · see citing works

Mitoferrin is essential for erythroid iron assimilation

Shaw, G. C., Cope, J. J., Li, L., Corson, K., Hersey, C., Ackermann, G. E., Gwynn, B., Lambert, A. J., Wingert, R. A., Traver, D., et al. (2006) · Nature · doi:10.1038/nature04512 · Cited by 624 · see citing works

Forging a field: the golden age of iron biology.

Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623 · see citing works

Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620 · see citing works

Oligodendrocytes and myelination: The role of iron

Todorich, B., Pasquini, J. M., Garcia, C. I., Paez, P. M., & Connor, J. R. (2008) · Glia · doi:10.1002/glia.20784 · Cited by 615 · see citing works

The redox chemistry of the Alzheimer's disease amyloid β peptide

Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608 · see citing works

Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells

Liuzzi, J. P., Aydemir, F., Nam, H., Knutson, M. D., & Cousins, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606424103 · Cited by 577 · see citing works

The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel

Dong, X., Cheng, X., Mills, E., Delling, M., Wang, F., Kurz, T., & Xu, H. (2008) · Nature · doi:10.1038/nature07311 · Cited by 572 · see citing works

Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux

Harris, Z. L., Durley, A. P., Man, T. K., & Gitlin, J. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10812 · Cited by 568 · see citing works

Glutaredoxin systems

Lillig, C. H., Berndt, C., & Holmgren, A. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.06.003 · Cited by 563 · see citing works

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537 · see citing works

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron

Morgan, N. V., Westaway, S. K., Morton, J. E. V., Gregory, A., Gissen, P., Sonek, S., Cangül, H., Coryell, J. C., Canham, N. L. E., Nardocci, N., et al. (2006) · Nature Genetics · doi:10.1038/ng1826 · Cited by 532 · see citing works

Intracellular iron transport and storage: from molecular mechanisms to health implications

Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526 · see citing works

Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice

LaVaute, T., Smith, S., Cooperman, S., Iwai, K., Land, W., Meyron-Holtz, E., Drake, S. K., Miller, G., Abu-Asab, M., Tsokos, M., et al. (2001) · Nature Genetics · doi:10.1038/84859 · Cited by 509 · see citing works

L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy

Oudit, G. Y., Sun, H., Trivieri, M. G., Koch, S. E., Dawood, F., Ackerley, C., Yazdanpanah, M., Wilson, G. J., Schwartz, A., Liu, P. P., et al. (2003) · Nature Medicine · doi:10.1038/nm920 · Cited by 480 · see citing works

Regulation of iron acquisition and storage: consequences for iron-linked disorders

De Domenico, I., McVey Ward, D., & Kaplan, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2295 · Cited by 464 · see citing works

Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel

Sun, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.17.2471 · Cited by 461 · see citing works

Iron trafficking inside the brain

Moos, T., Nielsen, T. R., Skjørringe, T., & Morgan, E. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04976.x · Cited by 421 · see citing works

Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver

Gunshin, H., Fujiwara, Y., Custodio, A. O., DiRenzo, C., Robine, S., & Andrews, N. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24356 · Cited by 419 · see citing works

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., Duyckaerts, C., Sazdovitch, V., Zhao, L., Garrick, L. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804373105 · Cited by 409 · see citing works

Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier

Fillebeen, C., Descamps, L., Dehouck, M., Fénart, L., Benaı̈ssa, M., Spik, G., Cecchelli, R., & Pierce, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7011 · Cited by 385 · see citing works

Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system

Jeong, S. Y., & David, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301988200 · Cited by 377 · see citing works

Natural Resistance to Intracellular Infections

Jabado, N., Jankowski, A., Dougaparsad, S., Picard, V., Grinstein, S., & Gros, P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1237 · Cited by 372 · see citing works

Scara5 Is a Ferritin Receptor Mediating Non-Transferrin Iron Delivery

Li, J. Y., Paragas, N., Ned, R. M., Qiu, A., Viltard, M., Leete, T., Drexler, I. R., Chen, X., Sanna‐Cherchi, S., Mohammed, F., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2008.12.002 · Cited by 355 · see citing works

A Novel Glycosylphosphatidylinositol-anchored Form of Ceruloplasmin Is Expressed by Mammalian Astrocytes

Patel, B. N., & David, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20185 · Cited by 327 · see citing works

Vesicular transmitter release from astrocytes

Montana, V., Malarkey, E. B., Verderio, C., Matteoli, M., & Parpura, V. (2006) · Glia · doi:10.1002/glia.20367 · Cited by 325 · see citing works

Lysosomes in iron metabolism, ageing and apoptosis

Kurz, T., Terman, A., Gustafsson, B., & Brunk, U. T. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0394-y · Cited by 302 · see citing works

Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat

Burdo, J. R., Menzies, S. L., Simpson, I. A., Garrick, L. M., Garrick, M. D., Dolan, K. G., Haile, D. J., Beard, J. L., & Connor, J. R. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1256 · Cited by 297 · see citing works

Brain iron uptake and homeostatic mechanisms: An overview

Burdo, J. R., & Connor, J. R. (2003) · BioMetals · doi:10.1023/a:1020718718550 · Cited by 292 · see citing works

Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood–brain barrier

Chang, J., Jallouli, Y., Kroubi, M., Yuan, X.-B., Feng, W., Kang, C., Pu, P., & Betbeder, D. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.035 · Cited by 280 · see citing works

Brain Injury After Intracerebral Hemorrhage: The Role of Thrombin and Iron

Hua, Y., Keep, R. F., Hoff, J. T., & Xi, G. (2007) · Stroke · doi:10.1161/01.str.0000247868.97078.10 · Cited by 273 · see citing works

Transport of Iron in the Blood‐Brain‐Cerebrospinal Fluid System

Bradbury, M. W. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020443.x · Cited by 270 · see citing works

Release of iron from ferritin requires lysosomal activity

Kidane, T. Z., Sauble, E., & Linder, M. C. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00505.2005 · Cited by 263 · see citing works

Huntingtin–HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease

Pal, A., Severin, F. F., Lommer, B. S., Shevchenko, A., & Zerial, M. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200509091 · Cited by 244 · see citing works

Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A in activated cells

Balsinde, J., & Balboa, M. A. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.002 · Cited by 238 · see citing works

Brain iron metabolism: Neurobiology and neurochemistry

Ke, Y., & Qian, Z. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236 · see citing works

The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review

Moos, T., & Morgan, E. H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.002 · Cited by 234 · see citing works

Redox metals and neu rodegenerative disease

Sayre, L. M., Perry, G. L., & Smith, M. A. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80035-0 · Cited by 217 · see citing works

Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier

Wu, L. J.-C., Leenders, A. G. M., Cooperman, S., Meyron-Holtz, E., Smith, S., Land, W., Tsai, R. Y. L., Berger, U. V., Sheng, Z.-H., & Rouault, T. A. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.066 · Cited by 210 · see citing works

The pivotal role of astrocytes in the metabolism of iron in the brain

Dringen, R., Bishop, G. M., Koeppe, M., Dang, T. N., & Robinson, S. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9375-0 · Cited by 209 · see citing works

Ferritin: a novel mechanism for delivery of iron to the brain and other organs

Fisher, J., Devraj, K., Ingram, J., Slagle‐Webb, B., Madhankumar, A. B., Liu, X., Klinger, M., Simpson, I. A., & Connor, J. R. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00599.2006 · Cited by 206 · see citing works

Iron metabolism in Parkinsonian syndromes

Berg, D., & Hochstrasser, H. (2006) · Movement Disorders · doi:10.1002/mds.21020 · Cited by 185 · see citing works

Iron Is Essential for Neuron Development and Memory Function in Mouse Hippocampus

Carlson, E. S., Tkáč, I., Magid, R., O’Connor, M. B., Andrews, N. C., Schallert, T. J., Gunshin, H., Georgieff, M., & Petryk, A. (2009) · Journal of Nutrition · doi:10.3945/jn.108.096354 · Cited by 185 · see citing works

Prevention of oxidant-induced cell death by lysosomotropic iron chelators

Persson, H. L., Yu, Z., Tirosh, O., Eaton, J. W., & Brunk, U. T. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00106-0 · Cited by 185 · see citing works

Brain iron deposition and the free radical-mitochondrial theory of ageing

Schipper, H. M. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.02.001 · Cited by 177 · see citing works

Tim‐2 is the receptor for H‐ferritin on oligodendrocytes

Todorich, B., Zhang, X., Slagle‐Webb, B., Seaman, W. E., & Connor, J. R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05678.x · Cited by 162 · see citing works

Modulation of Iron Uptake in Heart by L-Type Ca2+Channel Modifiers

Tsushima, R. G., Wickenden, A. D., Bouchard, R. A., Oudit, G. Y., Liu, P. P., & Backx, P. H. (1999) · Circulation Research · doi:10.1161/01.res.84.11.1302 · Cited by 157 · see citing works

Huntingtin-deficient zebrafish exhibit defects in iron utilization and development

Lumsden, A. L., Henshall, T. L., Dayan, S., Lardelli, M. T., & Richards, R. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm138 · Cited by 156 · see citing works

Transferrin and Iron Uptake by the Brain: Effects of Altered Iron Status

Taylor, E. M., Crowe, A. P., & Morgan, E. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06355.x · Cited by 149 · see citing works

Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease

Liu, G., Men, P., Kudo, W., Perry, G., & Smith, M. A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.064 · Cited by 148 · see citing works

Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood–brain barrier delivery in the mouse

Boado, R. J., Zhang, Y., Wang, Y., & Pardridge, W. M. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22135 · Cited by 146 · see citing works

Divalent metal-ion transporter DMT1 mediates both H+ -coupled Fe2+ transport and uncoupled fluxes

Mackenzie, B., Ujwal, M. L., Chang, M., Romero, M. F., & Hediger, M. A. (2005) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-1494-3 · Cited by 145 · see citing works

Deficiency of pantothenate kinase 2 ( Pank2 ) in mice leads to retinal degeneration and azoospermia

Kuo, Y., Duncan, J. L., Westaway, S. K., Yang, H., Nune, G. C., Xu, E. Y., Hayflick, S. J., & Gitschier, J. M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi005 · Cited by 139 · see citing works

Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers.

Xu, J., & Ling, E. (1994) · PubMed · Cited by 132 · see citing works

Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain

Siddappa, A. M., Rao, R., Wobken, J. D., Leibold, E. A., Connor, J. R., & Georgieff, M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10246 · Cited by 128 · see citing works

TRPMLs: in sickness and in health

Puertollano, R., & Kiselyov, K. I. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90522.2008 · Cited by 126 · see citing works

Determination of the Chelatable Iron Pool of Single Intact Cells by Laser Scanning Microscopy

Petrat, F., de GROOT, H., & Rauen, U. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1711 · Cited by 112 · see citing works

Mechanisms and regulation of transferrin and iron transport in a model blood–brain barrier system

Burdo, J. R., Antonetti, D. A., Wolpert, E. B., & Connor, J. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00590-6 · Cited by 106 · see citing works

Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium

Rothenberger, S., Food, M. R., Gabathuler, R., Kennard, M. L., Yamada, T., Yasuhara, O., McGeer, P. L., & Jefferies, W. A. (1996) · Brain Research · doi:10.1016/0006-8993(96)88505-2 · Cited by 105 · see citing works

Cellular iron transport

Garrick, M. D., & Garrick, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.018 · Cited by 102 · see citing works

Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1

Moos, T., Skjørringe, T., Gosk, S., & Morgan, E. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04023.x · Cited by 91 · see citing works

Is ferroportin–hepcidin signaling altered in restless legs syndrome?

Clardy, S. L., Wang, X., Boyer, P. J., Earley, C. J., Allen, R. P., & Connor, J. R. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.04.008 · Cited by 84 · see citing works

Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases

Vargas, J. D. H., Herpers, B., McKie, A. T., Gledhill, S., McDonnell, J. M., van den Heuvel, M., Davies, K. E., & Ponting, C. P. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(03)00242-5 · Cited by 82 · see citing works

Characterization and Distribution of Ferritin Binding Sites in the Adult Mouse Brain

Hulet, S. W., Hess, E. J., Debinski, W., Arosio, P., Bruce, K., Powers, S. K., & Connor, J. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.720868.x · Cited by 82 · see citing works

Iron Dysregulation and Neurodegeneration: The Molecular Connection

Lee, D. W. (2006) · Molecular Interventions · doi:10.1124/mi.6.2.6 · Cited by 80 · cited 1× · see citing works

Phospholipase A 2 plays an important role in myelin breakdown and phagocytosis during wallerian degeneration

De, S., Avilés‐Trigueros, M., Kalyvas, A., & David, S. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00241-0 · Cited by 80 · see citing works

Early iron deficiency anemia and later mental retardation

Pollitt, E. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.4 · Cited by 76 · see citing works

Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice

Wang, F., Paradkar, P. N., Custodio, Á. O., Ward, D. M., Fleming, M. D., Campagna, D. R., Roberts, K. A., Boyartchuk, V., Dietrich, W. F., Kaplan, J., et al. (2007) · Nature Genetics · doi:10.1038/ng2059 · Cited by 72 · see citing works

Distinct Targeting and Recycling Properties of Two Isoforms of the Iron Transporter DMT1 (NRAMP2, Slc11A2)†

Lam-Yuk-Tseung, S., & Gros, P. (2006) · Biochemistry · doi:10.1021/bi052307m · Cited by 72 · see citing works

Astrocytic Deformity and Globular Structures Are Characteristic of the Brains of Patients with Aceruloplasminemia

Kaneko, K., Yoshida, K., Arima, K., Ohara, S., Miyajima, H., Kato, T., Ohta, M., & Ikeda, S.-I. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.12.1069 · Cited by 62 · see citing works

The oxidative neurotoxicity of clioquinol

Benvenisti‐Zarom, L., Chen, J., & Regan, R. F. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.023 · Cited by 58 · see citing works

Role of transient receptor potential canonical 6 (TRPC6) in non-transferrin-bound iron uptake in neuronal phenotype PC12 cells

Mwanjewe, J., & Grover, A. K. (2004) · Biochemical Journal · doi:10.1042/bj20031187 · Cited by 58 · see citing works

Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides.

Ham, D., & Schipper, H. M. (2000) · PubMed · Cited by 58 · see citing works

Brain iron uptake in hypotransferrinemic mice: Influence of systemic iron status

Beard, J. L., Wiesinger, J. A., Li, N., & Connor, J. R. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20324 · Cited by 56 · see citing works

The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study

Abokrysha, N. T., & Rashed, L. A. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507085550 · Cited by 54 · see citing works

Transferrin receptors on the plasma membrane of cultured rat astrocytes

Qian, Z., To, Y., Tang, P., & Feng, Y. (1999) · Experimental Brain Research · doi:10.1007/s002210050916 · Cited by 52 · see citing works

Characterization of lectin-mediated brain uptake of HIV-1 GP120

Banks, W. A., & Kastin, A. J. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981115)54:4 · Cited by 49 · see citing works

Non-Protein-Bound Iron in Brain Interstitium of Newborn Pigs after Hypoxia

Sävman, K., Nilsson, U. A., Thoresen, M., & Kjellmer, I. (2005) · Developmental Neuroscience · doi:10.1159/000085990 · Cited by 21 · see citing works

Mechanisms of iron release from lysosomes

Nguyen, A., Zhao, N., Morrison, C. D., Gonzalez, A., Sauble, E., La, A.-T. H., Linder, M. C., & Knutson, M. D. (2009) · The FASEB Journal · doi:10.1096/fasebj.23.1_supplement.921.11 · Cited by 1 · see citing works

The role of iron in brain ageing and neurodegenerative disorders

Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819 · see citing works

Lysosomal Physiology

Xu, H., & Ren, D. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071649 · Cited by 1,028 · see citing works

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659 · see citing works

Oxidative stress in neurodegenerative diseases.

Chen, X., Guo, C., & Kong, J. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.05.009 · Cited by 572 · see citing works

The role of zinc, copper, manganese and iron in neurodegenerative diseases

Mezzaroba, L., Alfieri, D. F., Colado Simão, A. N., & Vissoci Reiche, E. M. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.07.007 · Cited by 524 · see citing works

Mucolipins: Intracellular TRPML1‐3 channels

Cheng, X., Shen, D., Samie, M., & Xu, H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.056 · Cited by 262 · see citing works

Iron Metabolism, Ferroptosis, and the Links With Alzheimer’s Disease

Yan, N., & Zhang, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01443 · Cited by 254 · see citing works

Brain iron metabolism and its perturbation in neurological diseases

Crichton, R. R., Dexter, D. T., & Ward, R. J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0470-z · Cited by 246 · see citing works

Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases

Ravanfar, P., Loi, S. M., Syeda, W. T., Rheenen, T. E. V., Bush, A. I., Desmond, P. M., Cropley, V., Lane, D. J. R., Opazo, C., Moffat, B. A., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.618435 · Cited by 231 · see citing works

Iron imbalance in neurodegeneration

Levi, S., Ripamonti, M., Moro, A. S., & Cozzi, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02399-z · Cited by 214 · see citing works

The metal ion hypothesis of Alzheimer’s disease and the anti-neuroinflammatory effect of metal chelators

Chen, L.-L., Fan, Y.-G., Zhao, L.-X., Zhang, Q., & Wang, Z.-Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106301 · Cited by 200 · see citing works

Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease

Guo, C., Wang, T., Zheng, W. H., Shan, Z., Teng, W., & Wang, Z. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.009 · Cited by 200 · see citing works

Role of the Blood–Brain Barrier in the Nutrition of the Central Nervous System

Campos‐Bedolla, P., Walter, F. R., Veszelka, S., & Deli, M. A. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.018 · Cited by 196 · see citing works

The Aging of Iron Man

Ashraf, A., Clark, M., & So, P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00065 · Cited by 158 · see citing works

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

Wang, Y., Wu, S., Li, Q., Sun, H., & Wang, H. (2023) · Advanced Science · doi:10.1002/advs.202300325 · Cited by 161 · see citing works

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

Morris, G., Berk, M., Carvalho, A. F., Maes, M. H. J., Walker, A. J., & Puri, B. K. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.036 · Cited by 154 · see citing works

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases

Cassano, T., Villani, R., Pace, L., Carbone, A., Bukke, V. N., Orkisz, S., Avolio, C., & Serviddio, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00124 · Cited by 148 · see citing works

Multilevel Impacts of Iron in the Brain: The Cross Talk between Neurophysiological Mechanisms, Cognition, and Social Behavior

Ferreira, A. C. E., Neves, P., & Gozzelino, R. (2019) · Pharmaceuticals · doi:10.3390/ph12030126 · Cited by 148 · see citing works

Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson’s disease after peripheral administration

Dexter, D. T., Statton, S. A., Whitmore, C. L., Freinbichler, W., Weinberger, P., Tipton, K. F., Corte, L., Ward, R. J., & Crichton, R. R. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0531-3 · Cited by 137 · see citing works

Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease

Gleason, A. J., & Bush, A. I. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00954-y · Cited by 134 · see citing works

Age and sex related differences in subcortical brain iron concentrations among healthy adults

Persson, N., Wu, J., Zhang, Q., Liu, T., Shen, J., Bao, R., Ni, M.-F., Liu, T., Wang, Y., & Spincemaille, P. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.07.050 · Cited by 133 · see citing works

Appraising the Role of Iron in Brain Aging and Cognition: Promises and Limitations of MRI Methods

Daugherty, A. M., & Raz, N. (2015) · Neuropsychology Review · doi:10.1007/s11065-015-9292-y · Cited by 131 · see citing works

Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders

Li, J., Jia, B., Cheng, Y., Song, Y., Li, Q., & Luo, C. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3999083 · Cited by 130 · see citing works

Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology

Moura, R. P., Martins, C., Pinto, S. F. T., Sousa, F., & Sarmento, B. F. C. C. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1583205 · Cited by 127 · see citing works

Chronic Aluminum Intake Causes Alzheimer's Disease: Applying Sir Austin Bradford Hill's Causality Criteria

Walton, J. R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132204 · Cited by 124 · see citing works

Iron and Mechanisms of Neurotoxicity

Salvador, G. A., Uranga, R. M., & Giusto, N. M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/720658 · Cited by 127 · see citing works

Autophagy–lysosomal-associated neuronal death in neurodegenerative disease

Nixon, R. A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02799-7 · Cited by 117 · see citing works

Iron handling in hippocampal neurons: activity‐dependent iron entry and mitochondria‐mediated neurotoxicity

Pelizzoni, I., Macco, R., Morini, M. F., Zacchetti, D., Grohovaz, F., & Codazzi, F. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00652.x · Cited by 110 · see citing works

Pharmacological inhibition of ferroptosis as a therapeutic target for sepsis-associated organ damage

Huo, L., Liu, C., Yuan, Y., Liu, X., & Cao, Q. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115438 · Cited by 112 · see citing works

Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities

Merelli, A., Rodríguez, J., Folch, J., Regueiro, M. R., Camins, A., & Lazarowski, A. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180110130253 · Cited by 105 · see citing works

Striatal Iron Content Predicts Its Shrinkage and Changes in Verbal Working Memory after Two Years in Healthy Adults

Daugherty, A. M., Haacke, E. M., & Raz, N. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4717-14.2015 · Cited by 105 · see citing works

Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders.

Miller, E., Morel, A., Saso, L., & Saluk, J. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666141209160556 · Cited by 86 · see citing works

Longitudinal Development of Brain Iron Is Linked to Cognition in Youth

Larsen, B., Bourque, J., Moore, T. M., Adebimpe, A., Calkins, M., Elliott, M., Gur, R., Gur, R., Moberg, P., Roalf, D., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2434-19.2020 · Cited by 92 · see citing works

Redox active metals in neurodegenerative diseases

Acevedo, K. M., Masaldan, S., Opazo, C., & Bush, A. I. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01731-9 · Cited by 101 · see citing works

Does Ceruloplasmin Defend Against Neurodegenerative Diseases?

Wang, B., & Wang, X. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180508113025 · Cited by 101 · see citing works

Age-related differences in iron content of subcortical nuclei observed in vivo: A meta-analysis

Daugherty, A. M., & Raz, N. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.12.040 · Cited by 101 · see citing works

The Role of Hippocampal Iron Concentration and Hippocampal Volume in Age-Related Differences in Memory

Rodrigue, K. M., Daugherty, A. M., Haacke, E. M., & Raz, N. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs139 · Cited by 98 · see citing works

The Relevance of Metals in the Pathophysiology of Neurodegeneration, Pathological Considerations

Jellinger, K. A. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00002-8 · Cited by 99 · see citing works

Systemic cobalt toxicity from total hip arthroplasties

Zywiel, M. G., Cherian, J. J., Banerjee, S., Cheung, A., Wong, F. S.-H., BUTANY, J. W., Gilbert, C. J., Overgaard, C. B., Syed, K., Jacobs, J. J., et al. (2016) · The Bone & Joint Journal · doi:10.1302/0301-620x.98b1.36712 · Cited by 97 · see citing works

Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseases

Gao, G., & Chang, Y. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00019 · Cited by 97 · see citing works

Traditional Chinese Formula Xiaoyaosan Alleviates Depressive-Like Behavior in CUMS Mice by Regulating PEBP1-GPX4-Mediated Ferroptosis in the Hippocampus

Jiao, H., Yang, H., Yan, Z., Chen, J., Xu, M., Jiang, Y.-M., Liu, Y., Xue, Z., Ma, Q., Li, X., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s302443 · Cited by 98 · see citing works

Iron deficiency in women

Coad, J. E., & Conlon, C. A. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834be6fd · Cited by 95 · see citing works

Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52

Zgajnar, N. R., Leo, S. A. D., Lotufo, C. M., Erlejman, A. G., Piwien‐Pilipuk, G., & Galigniana, M. D. (2019) · Biomolecules · doi:10.3390/biom9020052 · Cited by 94 · see citing works

Intracellular Fe2+ accumulation in endothelial cells and pericytes induces blood-brain barrier dysfunction in secondary brain injury after brain hemorrhage

Imai, T., Iwata, S., Hirayama, T., Nagasawa, H., Nakamura, S., Shimazawa, M., & Hara, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-42370-z · Cited by 94 · see citing works

Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection

da Silva, V. K., de Freitas, B. S., da Silva Dornelles, A., Nery, L. R., Falavigna, L., Ferreira, R. D. P., Bogo, M. R., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8514-7 · Cited by 91 · see citing works

Review: Iron metabolism and the role of iron in neurodegenerative disorders

Hadzhieva, M., Kirches, E., & Mawrin, C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12096 · Cited by 88 · see citing works

Can the emerging field of immunometabolism provide insights into neuroinflammation?

Lynch, M. A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101719 · Cited by 87 · see citing works

Exploiting transferrin receptor for delivering drugs across the blood-brain barrier

Paterson, J., & Webster, C. I. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.07.009 · Cited by 87 · see citing works

Protective effects of estrogen against cardiovascular disease mediated via oxidative stress in the brain

Lagranha, C. J., Silva, T. L. A., Silva, S. C. A., Braz, G. R. F., da Silva, A. I., Fernandes, M. P., & Sellitti, D. F. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.043 · Cited by 88 · see citing works

Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer’s Disease

Onukwufor, J. O., Dirksen, R. T., & Wojtovich, A. P. (2022) · Antioxidants · doi:10.3390/antiox11040692 · Cited by 83 · see citing works

Iron Exposure and the Cellular Mechanisms Linked to Neuron Degeneration in Adult Mice

Li, L.-B., Chai, R., Zhang, S., Xu, S., Zhang, Y., Li, H., Fan, Y., & Guo, C. (2019) · Cells · doi:10.3390/cells8020198 · Cited by 83 · see citing works

A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload

Sripetchwandee, J., Wongjaikam, S., Krintratun, W., Chattipakorn, N., & Chattipakorn, S. C. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.003 · Cited by 82 · see citing works

Fluorescent probes for the detection of catalytic Fe(II) ion

Hirayama, T. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.004 · Cited by 79 · see citing works

Accumulation of iron in the putamen predicts its shrinkage in healthy older adults: A multi-occasion longitudinal study

Daugherty, A. M., & Raz, N. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.12.045 · Cited by 78 · see citing works

Is insulin-like growth factor-1 involved in Parkinson’s disease development?

Castilla‐Cortázar, I., Aguirre, G. A., Femat‐Roldán, G., Martín‐Estal, I., & Espinosa, L. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02223-0 · Cited by 74 · see citing works

Role of Nrf2 in Parkinson’s Disease: Toward New Perspectives

Yang, X.-X., Yang, R., & Zhang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.919233 · Cited by 74 · see citing works

Aqueous extracts of avocado pear ( Persea americana Mill.) leaves and seeds exhibit anti-cholinesterases and antioxidant activities in vitro

Oboh, G., Odubanjo, V. O., Bello, F. O., Ademosun, A. O., Oyeleye, S. I., Nwanna, E. E., & Ademiluyi, A. O. (2016) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0049 · Cited by 74 · see citing works

Investigation of the association between cerebral iron content and myelin content in normative aging using quantitative magnetic resonance neuroimaging

Khattar, N., Triebswetter, C., Kiely, M., Ferrucci, L., Resnick, S. M., Spencer, R. G. S., & Bouhrara, M. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118267 · Cited by 73 · see citing works

Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder

Rahimian, R., Belliveau, C., Chen, R., & Mechawar, N. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.871997 · Cited by 73 · see citing works

Unraveling Binding Mechanism of Alzheimer’s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases

Shamsi, A., Mohammad, T., Khan, M. S., Shahwan, M. J., Husain, F. M., Rehman, M. T., Hassan, M. I., Ahmad, F., & Islam, A. (2019) · Biomolecules · doi:10.3390/biom9090495 · Cited by 72 · see citing works

An altered blood–brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson’s disease

Olmedo‐Díaz, S., Estévez-Silva, H. M., Orädd, G., af Bjerkén, S., Marcellino, D. J., & Virel, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.023 · Cited by 71 · see citing works

SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer’s disease

Gustavsson, T., Syvänen, S., O’Callaghan, P., & Sehlin, D. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00214-1 · Cited by 69 · see citing works

Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models

Yu, L., Zhang, X., Yang, Y., Li, D., Tang, K., Zhao, Z., He, W., Wang, C., Sahoo, N., Converso‐Baran, K., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz2736 · Cited by 68 · see citing works

Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain

Steiger, T. K., Weiskopf, N., & Bunzeck, N. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3617-15.2016 · Cited by 65 · see citing works

Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB

Kimura, S., & Harashima, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121216 · Cited by 64 · see citing works

R2 * and quantitative susceptibility mapping in deep gray matter of 498 healthy controls from 5 to 90 years

Treit, S., Naji, N., Seres, P., Rickard, J. N., Stolz, E., Wilman, A. H., & Beaulieu, C. (2021) · Human Brain Mapping · doi:10.1002/hbm.25569 · Cited by 65 · see citing works

Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment

Chen, P., Totten, M. S., Zhang, Z., Bucinca, H., Erikson, K. M., Santamarı́a, A., Bowman, A. B., & Aschner, M. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1581608 · Cited by 66 · see citing works

Hepcidin and its therapeutic potential in neurodegenerative disorders

Qian, Z., & Ke, Y. (2019) · Medicinal Research Reviews · doi:10.1002/med.21631 · Cited by 63 · see citing works

Potential role of iron in repair of inflammatory demyelinating lesions

Lee, N. J., Ha, S.-K., Sati, P., Absinta, M., Nair, G., Luciano, N. J., Leibovitch, E. C., Yen, C. C., Rouault, T. A., Silva, A. C., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126809 · Cited by 65 · see citing works

Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload

da Silva, V. K., de Freitas, B. S., Garcia, R. C. L., Monteiro, R. T., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., & Schröder, N. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0232-5 · Cited by 64 · see citing works

Oxidative Stress and Amyloid Beta Toxicity in Alzheimer’s Disease: Intervention in a Complex Relationship by Antioxidants

Chakrabarti, S., Sinha, M., Thakurta, I. G., Banerjee, P., & Chattopadhyay, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990152 · Cited by 63 · see citing works

Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol

da Silva, V. K., de Freitas, B. S., Dornelles, V. C., Kist, L. W., Bogo, M. R., Silva, M. C., STRECK, E. L., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.014 · Cited by 62 · see citing works

Fe(II) Ion Release during Endocytotic Uptake of Iron Visualized by a Membrane-Anchoring Fe(II) Fluorescent Probe

Niwa, M., Hirayama, T., Oomoto, I., Wang, D. O., & Nagasawa, H. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00939 · Cited by 61 · see citing works

Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer’s Disease

Lumsden, A. L., Rogers, J. T., Majd, S., Newman, M., Sutherland, G. T., Verdile, G., & Lardelli, M. T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00533 · Cited by 58 · see citing works

Disorders of heavy metals

Woimant, F., & Trocello, J. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4087-0.00057-7 · Cited by 60 · see citing works

DMT1 Expression and Iron Levels at the Crossroads Between Aging and Neurodegeneration

Ingrassia, R., Garavaglia, B., & Memo, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00575 · Cited by 60 · see citing works

NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives

McCann, S., & Roulston, C. L. (2013) · Brain Sciences · doi:10.3390/brainsci3020561 · Cited by 57 · see citing works

Iron transport kinetics through blood-brain barrier endothelial cells

Khan, A. I., Liu, J., & Dutta, P. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.02.010 · Cited by 57 · see citing works

Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals

Rasschaert, M., Emerit, A., Fretellier, N., Factor, C., Robert, P., Idée, J., & Corot, C. (2018) · Investigative Radiology · doi:10.1097/rli.0000000000000447 · Cited by 56 · see citing works

Hepcidin overexpression in astrocytes alters brain iron metabolism and protects against amyloid-β induced brain damage in mice

Zhang, X., Gou, Y., Zhang, Y., Li, J., Han, K., Xu, Y. X., Li, H., You, L., Yu, P., Chang, Y., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00346-3 · Cited by 54 · see citing works

Limbic system pathologies associated with deficiencies and excesses of the trace elements iron, zinc, copper, and selenium

Torres-Vega, A., Pliego‐Rivero, B., Otero, G., Gómez‐Oliván, L. M., & Vieyra-Reyes, P. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00521.x · Cited by 54 · see citing works

Iron overload causes endolysosomal deficits modulated by NAADP-regulated 2-pore channels and RAB7A

Fernández, B., Fdez, E., Gómez‐Suaga, P., Gil, F., Molina-Villalba, I., Ferrer, I., Patel, S., Churchill, G. C., & Hilfiker, S. (2016) · Autophagy · doi:10.1080/15548627.2016.1190072 · Cited by 53 · see citing works

A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin

Prabhu, S., Goda, J. S., Mutalik, S., Mohanty, B. S., Chaudhari, P., Rai, S., Udupa, N., & Rao, B. S. S. (2017) · Nanoscale · doi:10.1039/c7nr00305f · Cited by 54 · see citing works

Altered oligodendroglia and astroglia in chronic traumatic encephalopathy

Chancellor, K. B., Chancellor, S. E., Duke-Cohan, J. E., Huber, B. R., Stein, T. D., Alvarez, V. E., Okaty, B. W., Dymecki, S. M., & McKee, A. C. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02322-2 · Cited by 50 · see citing works

Multiple Mechanisms of Iron-Induced Amyloid Beta-Peptide Accumulation in SHSY5Y Cells: Protective Action of Negletein

Banerjee, P., Sahoo, A., Anand, S., Ganguly, A., Righi, G., Bovicelli, P., Saso, L., & Chakrabarti, S. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8328-4 · Cited by 52 · see citing works

A virtual water maze revisited: Two-year changes in navigation performance and their neural correlates in healthy adults

Daugherty, A. M., & Raz, N. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.09.044 · Cited by 50 · see citing works

Oxidative stress‐A direct bridge to central nervous system homeostatic dysfunction and Alzheimer's disease

Anwar, M. M. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3673 · Cited by 53 · see citing works

The effect of lead exposure on brain iron homeostasis and the expression of DMT1/FP1 in the brain in developing and aged rats

Zhu, G., Fan, G., Feng, C., Li, Y., Chen, Y., Zhou, F., Du, G., Jiao, H., Liu, Z., Xiao, X., et al. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2012.11.024 · Cited by 48 · see citing works

Hemin-Induced Death Models Hemorrhagic Stroke and Is a Variant of Classical Neuronal Ferroptosis

Zille, M., Osés-Prieto, J. A., Savage, S. R., Karuppagounder, S. S., Chen, Y., Kumar, A., Morris, J. H., Scheidt, K. A., Burlingame, A. L., & Ratan, R. R. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0923-20.2021 · Cited by 48 · see citing works

The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer’s Disease: from the Perspective of Ferroptosis

Wu, L., Xian, X., Tan, Z., Dong, F., Xu, G., Zhang, M., & Zhang, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03245-7 · Cited by 49 · see citing works

A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity

Rogers, J. T., Venkataramani, V., Washburn, C., Liu, Y., Tummala, V., Jiang, H. F., Smith, A., & Cahill, C. M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13671 · Cited by 47 · see citing works

Alpha-synuclein and iron: two keys unlocking Parkinson’s disease

Lingor, P., Carboni, E., & Koch, J. C. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1695-x · Cited by 47 · see citing works

Iron Dysregulation in Parkinson’s Disease: Focused on the Autophagy–Lysosome Pathway

Chen, L., Huang, Y., Cui, J., Song, N., & Xie, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00390 · Cited by 46 · see citing works

Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery

Steffens, R. C., & Wagner, E. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03385-w · Cited by 46 · see citing works

Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities

Pal, A., Cerchiaro, G., Rani, I., Ventriglia, M., Rongioletti, M. C. A., Longobardi, A., & Squitti, R. (2022) · Biomolecules · doi:10.3390/biom12091248 · Cited by 48 · see citing works

A matter of concern – Trace element dyshomeostasis and genomic stability in neurons

Wandt, V. K., Winkelbeiner, N., Bornhorst, J., Witt, B., Raschke, S., Simon, L., Ebert, F., Kipp, A. P., & Schwerdtle, T. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101877 · Cited by 43 · see citing works

Hypertension-related risk for dementia: A summary review with future directions

Daugherty, A. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.03.002 · Cited by 45 · see citing works

Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2

Hin, N., Newman, M., Kaslin, J., Douek, A. M., Lumsden, A. L., Nik, S. H. M., Dong, Y., Zhou, X., Manucat-Tan, N. B., Ludington, A. J., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227258 · Cited by 40 · see citing works

Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease

Maass, F., Michalke, B., Willkommen, D., Leha, A., Schulte, C., Tönges, L., Mollenhauer, B., Trenkwalder, C., Rückamp, D., Börger, M., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104677 · Cited by 41 · see citing works

Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease

Gu, X., Lai, D., Liu, S., Chen, K., Zhang, P., Chen, B., Huang, G., Cheng, X., & Lu, C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.949083 · Cited by 40 · see citing works

Brain iron transport

Qian, Z., & Ke, Y. (2019) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12521 · Cited by 117 · see citing works

Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases

Zheng, W., & Monnot, A. D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.006 · Cited by 302 · see citing works

The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseases

Campos-Escamilla, C. (2020) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2020.09.002 · Cited by 33 · see citing works

Mechanisms and regulation of transferrin and iron transport in a model blood–brain barrier system

Burdo, J. R., Antonetti, D. A., Wolpert, E. B., & Connor, J. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00590-6 · Cited by 106 · see citing works

Brain Iron Metabolism and Neurodegenerative Disorders

Sipe, J. C., Lee, P. L., & Beutler, E. (2002) · Developmental Neuroscience · doi:10.1159/000065701 · Cited by 94 · see citing works